Jennifer H. Shepherd
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jennifer H. Shepherd has a total of 93 co-authors. Here are the top co-authors by number of shared publications:
- Ruth Elizabeth Cameron
Cambridge Centre for Medical Materials, University of Cambridge
11 shared publications Serena M. Best
Cambridge Centre for Medical Materials, Department of Materials Science and Metallurgy, 27 Charles Babbage Road, Cambridge CB3 0FS, UK
6 shared publications- David V. Shepherd
Department of Materials science and Metallurgy, University of Cambridge, Cambridge, UK
4 shared publications Neil Rushton
Orthopaedic Research Unit, University of Cambridge , Cambridge , UK
4 shared publications- Hazel R. C. Screen
Centre for Predictive In Vitro Models Queen Mary University of London London UK
3 shared publications S. M. Best
Department of Materials Science and Metallurgy, University of Cambridge 1 , Cambridge, United Kingdom
3 shared publications
Latest Publications
- 6 August 2026
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 126
Study of the stochastic nature of nucleation in freeze-drying
- 6 August 2026
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 126
Study of the stochastic nature of nucleation in freeze-drying
- Open Access
- 26 March 2025
- Published by MDPI AG in Biomimetics
- Vol. 10 (4) , 204
Biomimetic Approaches in the Development of Optimised 3D Culture Environments for Drug Discovery in Cardiac Disease
Cardiovascular disease remains the leading cause of death worldwide, yet despite massive investment in drug discovery, the progress of cardiovascular drugs from lab to clinic remains slow. It is a complex, costly pathway from drug discovery to the clinic and failure becomes more expensive as a drug progresses along this pathway. The focus has begun to shift to optimisation of in vitro culture methodologies, not only because these must be undertaken are earlier on in the drug discovery pathway, but also because the principles of the 3Rs have become embedded in national and international legislation and regulation. Numerous studies have shown myocyte cell behaviour to be much more physiologically relevant in 3D culture compared to 2D culture, highlighting the advantages of using 3D-based models, whether microfluidic or otherwise, for preclinical drug screening. This review aims to provide an overview of the challenges in cardiovascular drug discovery, the limitations of traditional routes, and the successes in the field of preclinical models for cardiovascular drug discovery. It focuses on the particular role biomimicry can play, but also the challenges around implementation within commercial drug discovery.
- 26 March 2025
- Published by MDPI AG in Biomimetics
- Vol. 10 (4) , 204
Open AccessBiomimetic Approaches in the Development of Optimised 3D Culture Environments for Drug Discovery in Cardiac Disease
Cardiovascular disease remains the leading cause of death worldwide, yet despite massive investment in drug discovery, the progress of cardiovascular drugs from lab to clinic remains slow. It is a complex, costly pathway from drug discovery to the clinic and failure becomes more expensive as a drug progresses along this pathway. The focus has begun to shift to optimisation of in vitro culture methodologies, not only because these must be undertaken are earlier on in the drug discovery pathway, but also because the principles of the 3Rs have become embedded in national and international legislation and regulation. Numerous studies have shown myocyte cell behaviour to be much more physiologically relevant in 3D culture compared to 2D culture, highlighting the advantages of using 3D-based models, whether microfluidic or otherwise, for preclinical drug screening. This review aims to provide an overview of the challenges in cardiovascular drug discovery, the limitations of traditional routes, and the successes in the field of preclinical models for cardiovascular drug discovery. It focuses on the particular role biomimicry can play, but also the challenges around implementation within commercial drug discovery.
- Open Access
- 1 January 2025
- Published by Wiley in Journal of Tissue Engineering and Regenerative Medicine
- Vol. 2025 (1)
Collagen‐Based Scaffolds for Meniscal Repair and Regeneration
Meniscal injuries present a significant clinical challenge due to the limited self‐healing capacity of avascular regions and the unsatisfactory long‐term outcomes of current repair strategies. Collagen, the primary structural component of the meniscal extracellular matrix (ECM), plays a crucial role in maintaining its biomechanical integrity and guiding tissue regeneration. This review summarizes recent advances in collagen scaffolds technology, focusing on materials, collagen extraction, and scaffold fabrication methods, as well as their in vivo interactions with cells that regulate tissue regeneration. The mechanical enhancement of collagen scaffolds through crosslinking and reinforcement with synthetic polymers is discussed, alongside strategies for controlled degradation and biological integration. Despite remaining challenges in mechanical durability and long‐term stability, these developments position collagen‐based scaffolds as a promising avenue toward clinically viable meniscal repair solutions.
- 1 January 2025
- Published by Wiley in Journal of Tissue Engineering and Regenerative Medicine
- Vol. 2025 (1)
Open AccessCollagen‐Based Scaffolds for Meniscal Repair and Regeneration
Meniscal injuries present a significant clinical challenge due to the limited self‐healing capacity of avascular regions and the unsatisfactory long‐term outcomes of current repair strategies. Collagen, the primary structural component of the meniscal extracellular matrix (ECM), plays a crucial role in maintaining its biomechanical integrity and guiding tissue regeneration. This review summarizes recent advances in collagen scaffolds technology, focusing on materials, collagen extraction, and scaffold fabrication methods, as well as their in vivo interactions with cells that regulate tissue regeneration. The mechanical enhancement of collagen scaffolds through crosslinking and reinforcement with synthetic polymers is discussed, alongside strategies for controlled degradation and biological integration. Despite remaining challenges in mechanical durability and long‐term stability, these developments position collagen‐based scaffolds as a promising avenue toward clinically viable meniscal repair solutions.
- Open Access
- 21 August 2023
- Published by British Editorial Society of Bone & Joint Surgery in Bone & Joint Open
- Vol. 4 (8) , 612-620
Assessing the risk of re-fracture related to the percentage of partial union in scaphoid waist fractures
Assessing the risk of re-fracture related to the percentage of partial union in scaphoid waist fractures
- 21 August 2023
- Published by British Editorial Society of Bone & Joint Surgery in Bone & Joint Open
- Vol. 4 (8) , 612-620
Open AccessAssessing the risk of re-fracture related to the percentage of partial union in scaphoid waist fractures
Assessing the risk of re-fracture related to the percentage of partial union in scaphoid waist fractures
- Open Access
- 18 June 2021
- Published by KEAI Publishing in Bioactive Materials
- Vol. 8, 210-219
Avoiding artefacts in MicroCT imaging of collagen scaffolds: Effect of phosphotungstic acid (PTA)-staining and crosslink density
X-ray micro-computed tomography (μ-CT) can be used to provide both qualitative and quantitative information on the structure of three-dimensional (3D) bioactive scaffolds. When performed in a dry state, μ-CT accurately reflects the structure of collagen-based scaffolds, but imaging in a wet state offers challenges with radiolucency. Here we have used phosphotungstic acid (PTA) as a contrast agent to visualise fully hydrated collagen scaffolds in a physiologically relevant environment. A systematic investigation was performed to understand the effects of PTA on the results of μ-CT imaging by varying sample processing variables such as crosslinking density, hydration medium and staining duration.
- 18 June 2021
- Published by KEAI Publishing in Bioactive Materials
- Vol. 8, 210-219
Open AccessAvoiding artefacts in MicroCT imaging of collagen scaffolds: Effect of phosphotungstic acid (PTA)-staining and crosslink density
X-ray micro-computed tomography (μ-CT) can be used to provide both qualitative and quantitative information on the structure of three-dimensional (3D) bioactive scaffolds. When performed in a dry state, μ-CT accurately reflects the structure of collagen-based scaffolds, but imaging in a wet state offers challenges with radiolucency. Here we have used phosphotungstic acid (PTA) as a contrast agent to visualise fully hydrated collagen scaffolds in a physiologically relevant environment. A systematic investigation was performed to understand the effects of PTA on the results of μ-CT imaging by varying sample processing variables such as crosslinking density, hydration medium and staining duration.
- 1 August 2020
- Published by Elsevier in Drug Discovery Today
- Vol. 25 (8) , 1513-1520
Application of mesoporous silica nanoparticles as drug delivery carriers for chemotherapeutic agents
- 1 August 2020
- Published by Elsevier in Drug Discovery Today
- Vol. 25 (8) , 1513-1520
Application of mesoporous silica nanoparticles as drug delivery carriers for chemotherapeutic agents
- Open Access
- 22 April 2020
- Published by The Royal Society in Journal of The Royal Society Interface
- Vol. 17 (165) , 20190833
MicroCT analysis of connectivity in porous structures: optimizing data acquisition and analytical methods in the context of tissue engineering
Micro-computed X-ray tomography (MicroCT) is one of the most powerful techniques available for the three-dimensional characterization of complex multi-phase or porous microarchitectures. The imaging and analysis of porous networks are of particular interest in tissue engineering due to the ability to predict various large-scale cellular phenomena through the micro-scale characterization of the structure. However, optimizing the parameters for MicroCT data capture and analyses requires a careful balance of feature resolution and computational constraints while ensuring that a structurally representative section is imaged and analysed. In this work, artificial datasets were used to evaluate the validity of current analytical methods by considering the effect of noise and pixel size arising from the data capture, and intrinsic structural anisotropy and heterogeneity. A novel ‘segmented percolation method’ was developed to exclude the effect of anomalous, non-representative features within the datasets, allowing for scale-invariant structural parameters to be obtained consistently and without manual intervention for the first time. Finally, an in-depth assessment of the imaging and analytical procedures are presented by considering percolation events such as micro-particle filtration and cell sieving within the context of tissue engineering. Along with the novel guidelines established for general pixel size selection for MicroCT, we also report our determination of 3 μm as the definitive pixel size for use in analysing connectivity for tissue engineering applications.
- 22 April 2020
- Published by The Royal Society in Journal of The Royal Society Interface
- Vol. 17 (165) , 20190833
Open AccessMicroCT analysis of connectivity in porous structures: optimizing data acquisition and analytical methods in the context of tissue engineering
Micro-computed X-ray tomography (MicroCT) is one of the most powerful techniques available for the three-dimensional characterization of complex multi-phase or porous microarchitectures. The imaging and analysis of porous networks are of particular interest in tissue engineering due to the ability to predict various large-scale cellular phenomena through the micro-scale characterization of the structure. However, optimizing the parameters for MicroCT data capture and analyses requires a careful balance of feature resolution and computational constraints while ensuring that a structurally representative section is imaged and analysed. In this work, artificial datasets were used to evaluate the validity of current analytical methods by considering the effect of noise and pixel size arising from the data capture, and intrinsic structural anisotropy and heterogeneity. A novel ‘segmented percolation method’ was developed to exclude the effect of anomalous, non-representative features within the datasets, allowing for scale-invariant structural parameters to be obtained consistently and without manual intervention for the first time. Finally, an in-depth assessment of the imaging and analytical procedures are presented by considering percolation events such as micro-particle filtration and cell sieving within the context of tissue engineering. Along with the novel guidelines established for general pixel size selection for MicroCT, we also report our determination of 3 μm as the definitive pixel size for use in analysing connectivity for tissue engineering applications.
- 22 November 2019
- Published by Oxford University Press (OUP) in Postgraduate Medical Journal
- Vol. 96 (1132) , 94-101
Revolving doors of tendinopathy: definition, pathogenesis and treatment
The ultimate cure for the tendon pathology continues to elude current science. Despite great steps in technology, the causation and treatment is still not clear. The number of different theories and treatment modalities in the literature may confuse clinicians and patients. In this paper we outline the definitions, evolution of pathogenesis and treatment for tendinopathy. By highlighting these, the aim of this paper is to guide the practitioner in counselling and treating their patients.
- 22 November 2019
- Published by Oxford University Press (OUP) in Postgraduate Medical Journal
- Vol. 96 (1132) , 94-101
Revolving doors of tendinopathy: definition, pathogenesis and treatment
The ultimate cure for the tendon pathology continues to elude current science. Despite great steps in technology, the causation and treatment is still not clear. The number of different theories and treatment modalities in the literature may confuse clinicians and patients. In this paper we outline the definitions, evolution of pathogenesis and treatment for tendinopathy. By highlighting these, the aim of this paper is to guide the practitioner in counselling and treating their patients.
- Open Access
- 1 November 2018
- Published by Elsevier in Biomaterials
- Vol. 182, 135-144
Structurally graduated collagen scaffolds applied to the ex vivo generation of platelets from human pluripotent stem cell-derived megakaryocytes: Enhancing production and purity
- 1 November 2018
- Published by Elsevier in Biomaterials
- Vol. 182, 135-144
Open AccessStructurally graduated collagen scaffolds applied to the ex vivo generation of platelets from human pluripotent stem cell-derived megakaryocytes: Enhancing production and purity